Knowledge Centre
category guide

How to Choose a Spirometer

May 1, 2026· 9 min read· AI-generated

How to Choose a Spirometer

What procurement teams need to know before buying diagnostic lung-function equipment for a clinic, PFT lab, or occupational-health program.


What this is and who buys it

A spirometer measures how much air a patient can exhale — and how fast — producing the core indices that clinicians rely on to diagnose and monitor obstructive and restrictive lung diseases. The primary metrics are forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF). Those three numbers, combined with the FEV1/FVC ratio, sit at the center of every asthma and COPD workup, every pre-operative pulmonary risk assessment, and most occupational-health surveillance programs required under OSHA.

The buyers are varied. Primary-care and family-medicine clinics need a device that a medical assistant can operate reliably between patient slots. Pulmonology and PFT labs need higher throughput and may want integrated body-plethysmography and DLCO capability in the same software platform. Occupational-health programs — particularly those covering workers exposed to silica, coal dust, or cotton dust — need NIOSH-aligned surveillance workflows and defensible audit trails. Ambulatory surgery centers and pre-admission units use spirometry for pre-operative risk stratification. Clinical-trial sponsors are increasingly deploying Bluetooth-connected handhelds for decentralized monitoring [S8].

The market looks deceptively simple — a tube, a mouthpiece, a screen — but the differences between platforms have direct consequences for diagnostic accuracy, staff burden, infection control, and the total cost you'll pay over a seven-year device life.


Key decision factors

Sensor technology is the first fork in the road. Turbine-based sensors use a spinning rotor to infer flow; they're lightweight and inexpensive but require single-use or autoclaved rotors, and some designs show reduced sensitivity at very low flows. Ultrasonic transducers measure the transit time of sound waves across the flow stream, eliminating moving parts and offering calibration-free flow tubes with excellent low-flow sensitivity — an advantage when screening for early-stage COPD [S6]. Fleisch pneumotachograph designs (which measure differential pressure across a mesh resistance element) have a long clinical validation history and high stability, but they require rigorous cleaning discipline between patients because secretions affect accuracy.

ATS/ERS 2019 compliance is non-negotiable for any device being purchased today. The 2019 update tightened device accuracy from ±3% to ±2.5%, added a new A–F session-grading system, and updated the predicted-equation requirements [S1]. Many devices on the secondary market and some entry-level platforms were validated only against the 2005 standard. Ask vendors to show documentation — not a marketing claim — that their current firmware version meets the 2019 technical statement.

Disposables economics deserve a full three-year model, not a spot comparison. Some platforms require a single-use turbine or flow tube for every patient encounter; others use only a bacterial-viral filter (BVF) over a reusable pneumotach element. The per-test cost difference between these architectures can be substantial at high volumes, and it's rarely highlighted in the capital-cost quote.

Form factor maps closely to workflow. Handheld devices suit mobile occupational-health vans, remote clinics, and home-monitoring protocols; they sacrifice some display real estate and typically offer a narrower menu of maneuvers. PC-based desktop systems deliver larger waveform displays, richer software, and easier EMR integration, at the cost of portability. Many health systems end up with both: handhelds at satellite clinics, a desktop system in a central PFT lab for confirmatory testing.

EMR integration is where many implementations stall. Confirm that the device supports HL7 and/or GDT messaging, and — critically — ask for a reference site using your specific EMR (Epic, Cerner, athenahealth, etc.) at a comparable configuration. A "compatible" label on a data sheet is not the same as a validated, production-tested interface.

Quality-control feedback built into the software directly affects whether your staff consistently produce interpretable tests. The 2019 ATS/ERS grading system assigns an A–F letter to each session based on acceptability and repeatability criteria [S1]. Devices that implement this natively give operators real-time corrective cues and give medical directors an auditable quality record. Devices that simply display a waveform and flag a volume error leave QC to human judgment — and human habits are highly variable [S4].

Reference equations should include GLI (Global Lung Initiative) values with z-scores. Devices that ship only with older NHANES-derived references may produce systematically biased normal/abnormal calls for pediatric, elderly, or ethnically diverse populations.


What it costs

U.S. list prices for clinical spirometers are largely not publicly posted; the figures below are based on procurement-survey ranges and should be confirmed via written quotes from distributors.

  • Entry ($300–$1,500): Handheld and basic pocket units. Adequate for periodic screening when maneuver coaching and QC are handled by experienced staff.
  • Mid ($1,500–$5,000): Full-featured PC-based office spirometers and touchscreen handhelds with software licenses. This tier covers the majority of primary-care and occupational-health workflows.
  • Premium ($5,000–$15,000+): Desktop ultrasonic or pneumotach systems with full PFT software suites; lung-volume and DLCO-capable systems sit at the upper end. Appropriate for pulmonology labs and high-volume diagnostic programs.

Common use cases

The right device is defined as much by the workflow it sits in as by its technical specification.

  • Primary care / family medicine: Screening for asthma and COPD, bronchodilator-response testing, initial COPD severity grading — high value in a PC-based mid-range unit with good EMR integration.
  • Occupational health surveillance: OSHA-mandated programs for respirator medical evaluation and dust-exposed workers; requires NIOSH-aligned workflows, defensible audit trails, and portable form factors for on-site testing.
  • PFT laboratory: Full diagnostic spirometry, often alongside DLCO and body plethysmography; prioritize premium desktop platforms and validated predicted-equation libraries.
  • Decentralized / clinical-trial monitoring: Bluetooth-connected handhelds with encrypted data transmission and e-diary capability for remote patient reporting [S8].

Regulatory and compliance

Diagnostic spirometers are regulated in the United States as Class II devices under 21 CFR 868.1840, product code BZG, cleared via 510(k) premarket notification [S3]. Before purchasing any device, look up its 510(k) number in the FDA database and confirm the cleared intended use matches your clinical application — this matters particularly for devices marketed as "wellness" or "fitness" monitors that may carry no clinical clearance at all [S2].

The governing technical standard for device performance is ISO 26782:2009, which specifies accuracy, repeatability, linearity, and resistance requirements. Clinical performance — how tests are conducted, graded, and interpreted — is governed by the ATS/ERS 2019 Standardization of Spirometry statement [S1]. Any mains-powered or PC-connected unit should carry IEC 60601-1 and IEC 60601-1-2 (EMC) certification. For connected devices storing or transmitting protected health information, request the manufacturer's MDS2 form, a software bill of materials (SBOM), and documentation of PHI encryption in transit and at rest, user authentication, and audit-log capability — these are HIPAA compliance requirements, not optional features.


Service, training, and total cost of ownership

Installation burden is low for handhelds (Bluetooth pairing, app setup) but meaningful for PC-based systems, which require driver installation, HL7 interface mapping, and workstation validation. Budget for initial operator training explicitly aligned to ATS/ERS 2019 acceptability and repeatability criteria; the 2019 update introduced significant changes to technique coaching and grading, and experienced technicians accustomed to the 2005 standard may need structured retraining [S4].

Recurring operational costs include daily 3-L syringe verification by staff — the ATS/ERS standard requires at least three cycles at flows varying between 0.5 and 12 L/s — plus a documented weekly linearity check [S1, S7]. The 3-L calibration syringe itself requires annual recalibration; skipping this step risks systematic error that standard acceptance limits may fail to detect [S9]. Turbines or flow sensors must be replaced per the manufacturer's schedule; BVFs are consumed per patient encounter. Desktop platforms typically carry a 7–10-year expected service life; handhelds 5–7 years, with battery replacement commonly needed at the 2–3-year mark. Confirm that the vendor can guarantee parts availability for at least seven years post-purchase and ask for a service-level agreement specifying a maximum repair turnaround time.


Red flags to watch for

A vendor that cannot produce a specific FDA 510(k) number — or whose clearance predates the 2019 ATS/ERS accuracy tightening with no documented firmware update — is selling you regulatory exposure, not just an older product. Similarly, software that lacks GLI reference equations or the A–F session-grading scheme will produce results that are increasingly out of step with what referring physicians and accreditation reviewers expect.

"Calibration-free" marketing deserves scrutiny. Ultrasonic sensors genuinely require less frequent user calibration, but every reputable system still supports trended calibration data — research has shown that a reading within standard ATS/ERS volume acceptance limits can still be nearly 6 standard deviations from the device's own historical mean, flagging a pneumotach malfunction that the acceptance window would otherwise miss [S5]. Any platform that offers no trending or historical QC data is obscuring a meaningful risk. Finally, per-test disposable costs buried in the fine print — single-use turbines, for example — can dwarf the capital cost at volumes above 20–30 tests per week.


Questions to ask vendors

  1. Provide the FDA 510(k) number, product code, and documentation confirming validation against ATS/ERS 2019 and ISO 26782:2009 — not just the 2005 standard.
  2. What is the documented accuracy, linearity, and repeatability across the full 0.5–12 L/s flow range, and on which ATS/ERS test waveforms was this verified?
  3. Itemize the three-year total cost of ownership: device, software licenses, mouthpieces, BVFs, turbines or flow tubes per test, calibration-syringe annual service, and maintenance contract.
  4. Which EMRs do you have a production-validated HL7 interface with, and can you provide reference customer contacts at a comparable site size and EMR version?
  5. What is the warranty term, post-warranty service contract pricing, mean repair turnaround time, and parts-availability guarantee in years post-purchase?
  6. Provide the MDS2 form, cybersecurity SBOM, and details on PHI encryption, user authentication, and audit-log capabilities for connected configurations.

Alternatives

A refurbished desktop spirometer from an established manufacturer can reduce capital cost by 30–50%, but only if the unit has been restored to current firmware supporting the 2019 ATS/ERS standard and comes with a documented recalibration certificate. Units shipped before 2020 very often carry only the 2005-standard firmware. For organizations with constrained capital but moderate volume, a 36–60-month operating lease bundles device, software, and often service into a predictable monthly payment — though total five-year cost typically runs 15–25% higher than outright purchase. Very-low-volume occupational-health programs may find a capitated per-test managed-service contract attractive; above roughly 30 tests per week, the economics usually favor ownership. For multi-site health systems, a hub-and-spoke model — mid-range handhelds at satellite clinics feeding a premium desktop system at a central PFT lab for confirmatory interpretation — balances access and diagnostic depth without replicating expensive equipment at every site.


Sources

Sources

Browse vendors in

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.